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Since the introduction of clinica! cardiac tra~s~la~tat~o~ in 
ecember 1967, the growth in the number of trans 
operations has been directly dependent on the i 
and procurement of cardiac allograft donors. 
plantation was sustained and shown to be s 
Shumway and his colleagues in the 
vascular Surgery at Stanford uring 
of their program was dependent on the development of brain 
death criteria, medical criteria for proper donor selection, 
principles of donor management and technical details of 
donor procurement and preservation (1). Their pioneering 
work forms the basis for donor identification and manage- 
ment oday, and attention isnow perly focused on means 
of expanding the potential donor 
criieria for acceptance of donors a 
strategies to broaden the potential donor pool. VvTriie bio- 
logic replacement (either allograft or xenograft) promises to 
be preferable to mechanical replacement of the heart in 
terms of quality of life for the recipient, the number of 
patients with end-stage heafi faihue able to be treated with 
biologic heart replacement will remain strictly dependent on 
our ability to identify and procure suitable donor hearts. 
in esi 
The initial step in donor procurement must be the recog- 
nition and declaration ofbrain death of the donor. Estimates 
of potential donor availability indicate that 15% to 30% of 
individuals who could meet brain death criteria are not 
appropriately identified. Explanations for failure to recruit 
donors may include these possible physician characteristics: 
1) unfamiliarity with brain death criteria; 2) desire to avoid 
discussing the concept of brain death with the family; 
3) perception of a lengthy, “legalistic,” comp!ex process for 
organ donation; 4) lack of comfort with the concept of brain 
death. Surveys have indicated that the concept of brain 
death is, in fact, overwhelmingly accepted by physicians in 
the United States, and all 50 states and the District of 
Columbia have accepted brain death as a definition of death 
by statute or judicial decision. Thus, the timely determina- 
tion of brain death and physicians’ difficulty in discussing 
with families would appear to be the major 
has led to the acceptance of extended cri 
donors but concomitantly increased the im 
general criteria for the diagnosis of brain death, which most 
often can be determined on clinical grounds alone. The 
specih,-. application of brain de&b criteria must co t-m to 
individual state laws, which may contain minor variations 
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there be loss of function of the entire brain, i~c~~di~g 
the cortex and brain stem, and 2) that the loss of brain 
function be irreversible. Brain death may, of course, be 
present in the setting of persistent vital signs because of life 
support measures. Irreversibility is a key concept in the 
definition of brain death and implies that the cause is 
sufficiently well understood toconfidently predict he out- 
come. 
Be clinical def%tion for loss of entire brain function 
includes the fol?owing: 
1. LOSS of cortical function 
a. Presence of deep coma 
b. Lack of spontaneous motor activity (spinal rejexes 
may be present even with complete brain death) 
c. Absence of response to deep painful stimuli 
2. Loss of brain stem activity 
a. Absence of respiratory effort (apnea). (Apnea is dem- 
onstrated by preoxygenating the patient with 100% 
fractional inspiratory oxygen for 10 min before discon- 
necting the ventilator. After the ventilator is discon- 
nected, oxygen is provided by tracheal cannula at 
8 ltterslmin. The patient is observed for 5 to 10 mitt to 
allow carbon dioxide to accumulate and stimulate 
respiration. !f there are no respiratory eflorts an 
arterial blood gas measurement is obtained and the 
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ventilator is reconnected. If the arterial partial pres- 
sure of carbon dioxide is >60 mm Hg, the test is 
considered to be valid and apnea to be present.! 
Lack of pupillary or cornea1 reflexes. (Papillary con- 
striction in response to a bright iight is best demon- 
strated in a darkened room. The cornea is tested by 
touching with a cotton swab. Absence of papillary 
change in response to light or b/inking in response to 
cornea1 touch indicates brain stem inactivity.) 
Lack of gag or cough reflex, even with tracheal suc- 
tioning. 
Lack of oculocephalic or“doll’s eye reflex.” (“Doll’s 
eye” test is performed by turning the headfrom side to 
side with the head tilted forward 30”. If the eyes 
passively follow the rotating head withoat a lag, the 
oculocephalic rejIe,v is considered absent.) 
Lack of ocular-vestibular (“caloric”) response. (fnstil- 
lation of10 ml of ice water into the external ear canal 
should cause deviation of the eyes from the stimlrlated 
side. Absent eye movement response indicates lack of 
oculovestibuiar response.) 
Irreversibility of loss of brain jimctioiz requires that: 
Brain death has a defined etiology and there is no likeli- 
hood of recovery. 
The patient is normothermic, defined as a core tempera- 
ture >32,5C. 
Pharmacologic agents capable of central nervous ystem 
depression, neuromuscular blockade or disassociative 
coma are absent or below therapeutic levels. 
These criteria for loss of brain function persist for a 12- to 
24-h observation period. A shorter observation period 
(6 h) can be used if irreversibility can be confirmed by 
other means, such as demonstration f lack of cerebral 
blood flow. 
Confirmation ofthe diagnosis of brain death by a second 
physician isa prudent precaution and is required by law in 
some states. Laboratory confirmation, including the docu- 
mentation ofa flat elecrroencephalogram (EEG), is usually 
not required provided there is an obvious cause for irrevers- 
ible brain death and the observation period is sufficient. If
there is a question of etiology or irreversibility (e.g., with 
uncertainty regarding drug overdose), laboratory testing to 
include cerebral blood flow measurements or an EEG may 
be required to confirm the diagaosis of brain death. How- 
ever, it is possible to meet he criteria for brain death in the 
absence of electrocortical siience on the EEG. 
Very young age of the potential donor may also necessi- 
tate confirmatory laboratory testing. For premature infants 
of <32 weeks’ gestation, brain death criteria are not well 
established. For newborn full-term infants an observation 
period of 72 h has been recommended and should be 
buttressed by laboratory testing. Some investigators have 
recommended an even longer period of observation for 
premature infants. For infants <2 months of age, the r:com- 
mendations include two EEGs separated by 48 h or a brain 
blood fow stody. For infants between 2 months and 1 year of 
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age, a repeat EEG or a brain blood flow study should be 
performed 24 h s.fter the first EEG. For children > I year old, 
laboratory testing is not required unless there is doubt about 
the irreversibility of the cause, as in adults. 
should be documented in the chart with reference to clinical 
examination criteiria, laboratory testing (if done), as well as 
determination f irreversibility. 
The concept of brain death is accepted by the public at 
large, as has been confirmed by several studies including 
“The Presidential Commission for the Study of Ethical 
Problems in Medicine and Biomedical and 
search: Guidelines for the Determination 
Physicians ingeneral also accept t e concept of brain deal 
but are generally unfamiliar with its e t application. The 
criteria for establishing brain death are rough and specific 
to protect the individual, and are straightforward so as riot to 
be unduly burdensome on the family or attending physician. 
It is important for physicians to be familiar with the criteria 
for brain death so that the option of organ donation can be 
presented tothe family in a timely and unambiguous fashion. 
The screening ofpotential cardiac donors is accomplished 
in three phases. Primary screening is done by organ procure- 
ment specialists who work for the nonprofit organ procure- 
ment agencies. Information pertinent to all organ dcnati’on is
obtained initially. including body size, ABO blood type, 
hepatitis B and human immunodeficiency virus (HIV) sero- 
logic data, io~o~.matio~ on caDse of death and clinical course 
and routine laboratory data. Secondary screening is done by 
cardiac surgeons or cardiologists. Information relevant to 
cardiac donation includes determination of the circum- 
stances leading to severe brain injury, extent of other 
(especially thoracic) injuries, the extent of treatment re- 
quired to sustain an acceptable hemodynamic status, base- 
line electrocardiogram (ECG), chest X-ray film, arterial 
blood gas analysis nlnd echocardiogram. The purpose of this 
secondary screen is tu provide nough information to decide 
whether to implement the tertiary screen, which is inspec- 
tion of the heart by a “harvesting” surgeon. 
Because of a profound shortage of cardiac organ donors 
and high pretransplantation mortality rates of patients listed 
for heart transplantation, it is clear that donor screening 
strategy should be liberal. Conversely, because primary 
graft failure is almost always associated with death of the 
heart ransplant recipient, he screening strategy must iden- 
tify hearts that will reliably support he circulation in the 
immediate posttransplantation period. 
From the preceding information obtained on the primary 
and secondary screen, it is possible to devise ~1 system of 
absolute and relative contraindication t  the use of the donor 
heart for transpiantation. However, because the continuing 
severe shortage ofcardiac donors, it is important to empha- 
size inrlasivity and thoughtful evaluation and consideration 
of every potential donor heart. 
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P. V ~~s~tjvity (? exce 
eiutivs co,rl~(~indicclfiorw idrr 
1. Hepatitis surface antigen positivity (? exce 
4. History of metastatic cancer 
5. Extensive chest wall trauma with evidence of cardiac 
contusion by EC6 or echocardiography 
6. olonged hypotension, d fined as a systolic blood pres- 
re <60 mm Hg for >6 
7. Recurrent supraventricular ar hythmia 
8. Prolonged need for inotropic support, de 
dopamine dosage >20 pgiiig per min for 
comparable dosage of other beta-agonist or e 
norepinephrine, or dobutamine for the same period 
9. Prolonged resuscitation time after card~op~~mo~ary ar- 
rest, defined as attempted cardiopulmonary resuscita- 
tion for >3Q min performed within 24 h of organ barvest 
or multiple pisodes of attempted card~o~~~mo~ary re- 
suscitation 
10. Severe left ventricular hypertrophy on electrocardio- 
gram or echocardiogram 
1 I. Echocardiogram revealing moderate hypokinesca. which 
is typically segmental in brain injury, with shortening 
fraction 10% to 25% 
12. Noncriticrli coronary disease WR al-trriogram 
13. History of carbon monoxide inhalation, with blood 
carboxyhemoglobin ~20% 
14. Hkstory of intravenous drug abuse 
The decision to use a donor with a relative contraindica- 
tiou depends on the recipient’s clinical situation, and to 
seme extent on the size relation between the prospective 
donor and recipient. The pulmonary artery pressures inthe 
recipient also affect the decision when there is mild to 
moderate myocardial dysfunction i  the donor; higher pres- 
sures will predictably require a stronger donor heart. 
It is recommended that coronary arteriography be per- 
formed in male donors >45 years of age and in women 
owever, the use of 
made by the surgeon at 
LJILJMIC\r Vi WM. LUX. ,G r%rdiQrcontusion is best evaluated by 
inspection. 
resulting from accident; homicide or 
suicide. Thus, in most cases local coroners must 
tacted ?o obtain permission for recovery of org 
tissue. The Uniform Anatomical Gift Act adopted m 
dls for, but does not require, persons >lS years 
sign a card indicating willingness to donate body 
transplantation a d other medical purposes. In the U.S., the 
ordinary protoco! is to verify consent with the family. 
consent has not been indicatkd with a donor card signature. 
the family is approached rn the same fashio 
should be obtained from the next of kin or from a 
has authorized pswer of attorney. It
be a cc?sensus among family me 
shopld be explored sensitively by t 
dinatocs kvolved. The local organ procure 
should be contacted as soon as declaration ofbrain death is 
arark&ei~. 
Familie-, mi*st be approached in a sensitive and caring 
manner, preferably by a professional coordinator, with suf- 
ficient ime allowed for their understanding and acceptance 
of the death of the donor. It is important for the family t0 
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have an opportunity for privacy during their discussions of
these matters. Information given to the family should include 
examples ofhow patients benefit from transplantation (with- 
out reference to specific potential recipients), and reassur- 
ance that no additional medical costs will be incurred by the 
family because of the donation In addition, itis important to
remind the family that the body will not be disfigured as a 
result of the organ donation. 
r 
Basic principles of cardiac donor management are now 
we!! established. After brain death as been declared and the 
suitability for cardiac aiiografting has been determined by 
history, physical examination. electrocardiography and 
echocardiography, themain goal of donor medical manage- 
ment is to maintain hemodynamic stability. In the intensive 
care unit, continuous monitoring of intraarterial pressure, 
central venous presaurt: and indwelling urinary catheter 
output is mandatory. Insertion of a Swan-Ganz pulmonary 
artery catheter is not routinely recommended unless it has 
been previously placed to assess cardiac performance. Do- 
nors have usually had fluids restricted to minimize cerebra! 
edema nd are therefore hypovoiemic; fluid resuscitation 
should be initiated with a boius infusion of 1,000 ml of a 
balanced salt solution and adequate hydration maintained by 
hourly infusion of 100 to 150 ml in addition to the past hour’s 
urinarv output. Adequate fluid administration should main- 
tain systolic blood pressure >!OO mm Hg if the central 
venous pressure is Cl0 to 12 mm Hg. Hypotension despite 
adequate filling pressure is treated with dopamine. The 
dosage is titrated to maintain systolic performance: how- 
ever, infusions >7.5 to IO &kg per min should be avoided. 
Crystalloid rehydration may amplify the effects of previous 
blood loss, necessitating transfusion ofred ceils to maintain 
hematocrit levels above 30%. Sufficient red ceil mass is 
particularly critical for multiple organ donors because the 
harvesting procedure is of 2 to 4 h duration and results in 
significant blood loss. 
Fluid management af er brain death is often complicated 
by the development of diabetes insipidus due to pituitary 
nonfunction. Urinary output ~300 ml/h is a sign of diabetes 
insipidus and should be treated with infusion of parenteral 
vasopressin titrated to keep urinary volume <I50 ml/h. 
Hemodynamic lability of the donor can be evidenced by 
hypertension as well as hypotension. Increased systemic 
Pressure results when vasopressin s used and increased 
inkmania! pressure also causes massive sympathetic dis- 
charge with attendant vascular constriction. Sodium nitro- 
prusside is the preferred rug for rapid and effective after- 
load reduction. 
In addition to fluid management, meticulous attention to 
lnaintaining ornm! electrolyte l vels, acid-base balance and 
oxygenation is critical. The large volume of parenteral 
infusions and urinary output can cause hy~er~atremia and 
hypokaiemia. Hourly potassium s~p~~er~e~ta~o~ is nsually 
required. By definition, al! donors are ventilator dependent 
and frequent blood gas analysis allows correction of in- 
adequate oxygenation and alterations inp Brain death is 
also associated with low pressure, neur nit pulmonary 
edema. Frequent endotracheai suctioning and positive nd- 
expiratory pressure usually are required. Lack of thermal 
regulatory control can be overcome by the use of beating 
blankets or antipyretic agents, as indicated. After b!ood, 
sputum and urine cultures are obtained, broad spectrum 
antibiotic treatment should be initiated. 
The hypothetical relation between i:ardiac 
and depressed circulating levels of free triiodot 
prompted several investigators totreat donors with cxoge- 
nous thyroid hormone suppiementation. At present, the 
efficacy of such therapy is unproved and it should not be 
routinely used. 
Intraoperative management bythe anesthesiologist is an 
extension of the strict attention to detail required in the 
intensive care unit. Heart procurement today is most often 
part of a coordinated effort by several transplant teams 
whereby the liver, kidney;, lungs and pancreas may also be 
harvested (3). In regard to timing of explantation, the heart 
takes priority over the other viscera. Visual inspection and 
palpation of the heart are the last potential exclusionary 
steps in determining donor suitability. Palpable thrills over 
the great vessels, cbvious atherosclerotic lesion of epicardia! 
coronary arteries or areas of myocardial contusion should 
preclude transplantation. 
The surgical procedure isperformed as follows. The aorta 
and pulmonary artery are dissected superiorly to the level of 
the innominate artery and bifurcation, respectively. The 
superior vena cava is encircled and dissected superiorly to 
the level of the azygous vein. When the abdominal team has 
finished their dissection, the patient is heparinized and a 
cardiopiegic cannuia placed in the ascending aorta. The 
superior vena cava is doubly ligated and divided as far 
cephalad as possible to avoid injury to the sinoatrial node. 
Simuitaueously, the ascending and descending aortas are 
clamped and the intracoronary infusate is perfused to arrest 
the heart. The inferior vena cava is divided at the diaphragm 
to vent the liver perfusate. The right superior pulmonary 
vein is incised to vent the heart and avoid distension. 
Copious topical iced saline solution enhances cardiac hypo- 
thermia. Cardiopiegic solution, I to 1.5 liters, is given 
depending cm the rapidity of electromechanical arrest. After 
infusion, the heart is excised at the pericardial reflections 
starting with completion of the inferior vena cava incision, 
then the pulmonary veins and finally division of the aorta nd 
pulmonary arteries at the level of the innomina-e artery and 
bifurcation, respectively. The heart is brought o a back 
table where it is rinsed thoroughly with saline solution. The 
h of safe arrest in 
est has focused on utilizing University of Wisconsin solution 
for cardiac preservation. solution is an intracellular 
formula with several antio nts, oncotic agents and meta- 
es that has transformed I 
longed ischemic times. 
evidence suggests hat University of 
increase the safe ischemic time, initial ciinical studies have 
only reflected effective preservation fUi the 4 to 5-h time 
limit currently constraining aiternative flush and storage 
modalities. 
The number of centers perfotming heart ransplantation 
has increased ramaticai~y in the 1986s, from 82 centers 6n 
1983 to I31 in 1987. In 1988, atotal of 1,529 heart ransplan- 
tations were performed at 109 hospitals. Nonetheless, the 
potential demarrd for heart ransplantation is far from being 
met by our health care system. In E9g8, 900 patients re- 
mained on waiting lists, three times the number awaiting a
heart transplant in 1986. The General Accounting Office 
estimates that in 1988 >50f! people died while waiting for a 
heart. In 1989 nearly 2,000 people on organ transplant 
waiting lists died. Moreover, while patient need and demand 
are not being met, our organizational capacity is not being 
used in an optima! way, Ninety-one of I3i programs re- 
ported in 1988 that they bad preformed <12 transplant 
procedures. 
01x obvious response to this situation is !o attempt to 
increase the supply of donor bearts available. Legal changes 
(such as presumed consent laws) and more support for 
public education on the issue could facilitate the organ 
donation consent process. New commcnicatio. technologies 
and sharing networks can be utdized to ensure that the 
ration. 
Donor criteria can be 
way of increasing the pool of usable kearts is to 
turn to mo~b~rna~ donors. 
using pigs. may be possible 
will facilitate IArge rmmbers of tra~s~~a~ts. Xemograft~~g is 
the most compeL, ZL..o L__I inn t~n~-t~rm sohrtion to the cardiac donor 
problem, a., is discussed by Task Force 6. 
In addition to broadening the pool, the other method of 
increasing the supply of organs is to increase the frequency 
of consent among those already within the pool. Sevesal 
of finamcial incen- 
it an in-kind benefit for des 
ways G: ckumventinip this 
survivors are possible 
this schems,:: are tha: :t would contammate he mformed 
consent prccess, and would create a con&t of ~~~~~es~ 
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dyna& in family consent. Recent surveys also indicate that 
it is opposed by health care professionals, such as neurosur- 
geons, who might be even less willing than they now are to 
raise the issue of donation with families. Hence, it has been 
suggested that a policy of financial incentives could backfire, 
and lead to a net reduction of available organs. 
2. From uired request to presumed consent laws. In 
recent year ne cause of low donation rates has been 
thought to be the unwillingness of health care professionals 
to approach family members oon after death to request 
consent for organ donation. Signed onor cards are rare or 
rarely found; in any case, there is a universal reluctance to
take organs even when such a card is found with the 
deceased unless the consent of the next of kin is also 
obtained. The passage of laws and regulations requiring 
hospitals to request consent for donation have been one 
response. 
When these measures have not produced the desired 
results, the next logical move is to go to a system of 
“presumed consent” in which the deceased person is pre- 
sumed to consent o donation unless that person, or the 
family, takes active steps to object. Two lines of argument 
support this approach. One is that he majority of people do, 
in fact, agree with organ donation but have not, or do not 
wish to, actively contemplate i  in advance. Under presumed 
consent, he “silent consenters” will not be lost as they are 
in the present system, which is an ostensible required 
request system in which the active burden of consent still 
lies on the donor family. The second line of argument 
supporting presumed consent is the notion that donor organs 
are properly seen as a social or communal resource. Com- 
munal symbolism and perhaps even communal bond are 
strengthened by reversing the presumption about donation. 
It is highly selfish and individualistic, sothe argument goes, 
to presume that individuals do not wish to donate unless they 
actively say they do. In Austria, where presumed consent is 
practiced, the rate of recovery of cadaveric kidneys is almost 
double that of the U. S. During 1990, there were 19 donors 
per million population i  the U. S. and some 30.7 donors per 
million in Austria (4). 
eco S 
T~L Task Force recommends that the medical commu- 
ni:;, &u-k toward the following goals: 
1. Standardization f donor management and encourage- 
ment of education of critical care specialists indonor man.. 
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agement. It is suggested that the Ame~ca~ College of 
Cardiology, the American College of Chest Physicians and 
the Society of Critical Care Medicine form ar, ad 
commiitee to explore the development of specific trainin 
donor management for critical care physicians and .the 
formal incorporation of these physicians into the procure- 
ment process 
2. Emphasis n public education regarding the success of 
cardiac transplantation and the benefits of presumed consent 
! :; Q$T 
3. Enac resumed consent I 
4. Enco of retrospective a 
ies ol’ donor criteria s they relate to outcome 
5. Improvement in organ procurement 
through mechanisms such as the national 
the Agency for Wealth Care Policy and 
ment of organ procurement organization performance stan- 
dards for adult and pediatric recovery. Required istribution 
of organ procurement organization performance data, such 
as that now compiled by the Association of Organ Procure- 
ment Organizations 
6. Expansion of the donor pool 
C. 
d. 
Expaniqn of criteria based on Recommendation 4 
Recogniticln that anencephaly represents a uni 
category of brain death, which warrants erious 
evaluation 
Research ;nto potentially reversible cardiac dys- 
function tiat is related to brain injury 
Encouragement of coroners and district attorneys 
to facilitate organ donation 
7. Encouragement of participation by on-site cardiolo- 
gists in donor evaluation, including performance of echocar- 
diography and coronary arteritigraphy when indicated 
8. Advocacy for increased participation by transplant 
cardiologists in the governance oforgan procurement agen- 
cies 
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